1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Italy >
  5. 3SBio Acquires Sirton Pharmaceuticals

M&A Deal Summary

3SBio Acquires Sirton Pharmaceuticals

On January 26, 2015, 3SBio acquired life science company Sirton Pharmaceuticals

Acquisition Highlights
  • This is 3SBio’s 1st transaction in the Life Science sector.
  • This is 3SBio’s 1st transaction in Italy.

M&A Deal Summary
Date 2015-01-26
Target Sirton Pharmaceuticals
Sector Life Science
Buyer(s) 3SBio
Deal Type Add-on Acquisition

Target

Sirton Pharmaceuticals

Villa Guardia, Italy
Sirton Pharmaceuticals SpA is a pharmaceutical contract manufacturing company located in Villa Guardia, near Cuomo, Italy. Sirton produces injectable pharma products, including pre-filled syringes, liquid vials, freeze-dried vials and ampoules, and pharmaceutical development services including lyophilization process development, analytical method development and validation, stability studies and manufacturing of clinical study materials.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

3SBio

Shenyang, China
Category Company
Founded 1993
Sector Life Science
Employees6,268
Revenue 9.1B CNY (2024)
DESCRIPTION

3SBio is a biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products. 3SBio was incorporated in 1993 and is based in Shenyang, China.

DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 2
Type: Add-on Acquisition M&A Deals 1 of 2
Country: Italy M&A 1 of 1
Year: 2015 M&A 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-24 Zhejiang Wansheng Pharmaceutical Co.

Zhejiang, China

Zhejiang Wansheng Pharmaceutical Co., Ltd. is a pharmaceutical company.

Buy CN¥528M
Mergr

Solution for

Product

Company

Legal